0% found this document useful (0 votes)
337 views

Method Validation Part 2

The document discusses several CLSI guidelines for evaluating precision in clinical laboratories: - EP5-A2 and EP15-A2 provide protocols for manufacturers and laboratories to validate claims of test precision. - Validation of reference intervals can involve direct adoption if test methods and populations are comparable, or statistical comparison of reference samples to transferred intervals. - Parametric and non-parametric statistical methods can be used to compare reference ranges, with non-parametric methods like the Mann-Whitney U test often preferred for reference interval data.

Uploaded by

Melody
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
337 views

Method Validation Part 2

The document discusses several CLSI guidelines for evaluating precision in clinical laboratories: - EP5-A2 and EP15-A2 provide protocols for manufacturers and laboratories to validate claims of test precision. - Validation of reference intervals can involve direct adoption if test methods and populations are comparable, or statistical comparison of reference samples to transferred intervals. - Parametric and non-parametric statistical methods can be used to compare reference ranges, with non-parametric methods like the Mann-Whitney U test often preferred for reference interval data.

Uploaded by

Melody
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 15

CLSI Precision Protocol

EP5-A2
Guidelines intended primarily for manufacturers of in vitro
diagnostic methods
EP15-A2
Guidelines for validation of manufacturer’s method
performance specifications
Terminology
Repeatability vs. reproducibility (ISO standards)
Sample vs. specimen
Total precision vs. within-laboratory precision
CLSI Guideline EP5-A2

Guidelines for manufacturers of IVD devices and methods


(or user
user-modified
modified methods)
Four elements define conditions: time, operator,
calibration, instrument
Familiarization period (5 days)
Day-to-day precision
Two concentrations twice a day for 20 days
Within-run precision
20 consecutive assays
Recommend “pooling” results of several within-run evaluations
Outliers (> 5.5
5 5 SD)
CLSI Guideline EP15-A2

Specifies how a laboratory should verify the analytical


precision claims made by the manufacturer
Procedure
Two specimens once a day in triplicate, for five consecutive days
Triplicates define within-run precision
If the SD (or CV) is less than the manufacturer’s
specifications,
ifi ti then
th theth precision
i i claim
l i iis validated
lid t d
If the SD (or CV) is greater than the manufacturer’s
specifications then a Chi
specifications, Chi-square
square test can be used to
assess the statistical significance of the difference
Validation of Reference Intervals

CLIA 88 requires validation of reference intervals


42 CFR 493.1253 (Subpart K):

Verify that the manufacturer's reference intervals (normal


values) are appropriate for the laboratory's
laboratory s patient population
population.

CLIA does not specify how reference intervals are to be


validated
lid t d
Note that CLIA does not require laboratories to establish their
own reference intervals, only to verify that manufacturer’s
reference intervals are appropriate for their patient population
CLSI has provided guidance in meeting this CLIA
standard
CLSI Document C28-A3

“Defining, Establishing, and Verifying Reference Intervals


in the Clinical Laboratory; Approved Guideline
Guideline—Third
Third
Edition” (2008)
Transference (adoption of a reference interval established
by another laboratory)
Comparability of analytical systems
C
Comparability
bilit off ttestt subject
bj t population
l ti
Validation
Subjective method (non-statistical)
(non statistical)
Small sample method
Larger sample method
Comparability of Analytical Methods

Are they the same platform and method?


Some platforms support more than one method
Some methods can be adapted to multiple platforms
Is the measurement principle the same?
N h l
Nephelometry
t vs. chemiluminescent
h il i t iimmunoassay
“One-step” vs. “two-step” methods (e.g., free T4)
Direct vs. indirect potentiometry
p y
Do the methods correlate with each other?
Slope and y-intercept; standard error of the estimate
If a proportional bias exists between the methods
(slope ≠ 1.0), can the reference range be adjusted
based on the regression equation?
Comparability of Test Subject Populations

Demographic factors that may influence the reference


intervals for laboratory tests:
Age (pediatric vs. elder care)
Sex (women’s hospitals)
Race (relatively minor)
Altitude (hematology)
Latitude (Vitamin D)
Diet
Equivalence of the analytical methods and the test
subject populations are the basis of the subjective
method of reference interval transference
Small Sample Validation

Procedure:
Select 20 healthy subjects in the local population
If at least 18 of the 20 fall within the reference interval to be
transferred, the range is validated
If 16 or 17 fall
f ll within
ithi th
the reference
f iinterval,
t l select
l t 20 additional
dditi l
subjects, and if at least 18 of the second set of subjects fall
within the reference interval, the range is validated
If neither of the above conditions is met, the range is not
validated
The statistical basis for this validation test is a binomial
distribution
r > 2; n = 20; p = 0.05; P(>2;20;0.05) = 0.075
Larger Sample Validation

Procedure
Select 60 (or more, but less than 120) healthy individuals as
the local reference population
Calculate the reference range (non-parametrically) for the local
reference population
Compare the calculated reference range for the local reference
population with the range to be transferred
Alternatively, the local and reference data can be
compared by a robust (non-parametric) method
Parametric vs. Non-Parametric Statistics

Parametric methods are based on statistical distributions


Student s t, χ2, F
Examples: Student’s F-test,
test, etc.
Statistical distributions characterize data with a limited set of
descriptors, such as mean and standard deviation
Non-parametric methods do not assume any particular
distribution of the data
Sometimes called “distribution-free
distribution-free methods”
methods
Generally requires raw data, rather than mean and standard
deviation
Examples: Mann-Whitney U (or Wilcoxen rank-sum) test,
Spearman’s rank correlation coefficient, Wald–Wolfowitz runs test
Reference ranges often have irregular distributions
Mann-Whitney U Test

28 9
3 12 32
18 35 21
10 16
7 30
32 5
2 3 27
16
6 6
25 10
6
13 19 15
24

2,3,3,5,6,6,7,9,10,10,12,13,15,16,16,18,19,21,24,25,27,28,30,32,32,35

Mann-Whitney
Mann Whitney P
P=0.48
0.48
Monte Carlo Simulations

Reference
database x x ± SDx

N = 20
Mean, SD

N = 20
Mean, SD

N = 20
Mean, SD
Key Concepts

Method “sensitivity” is an ambiguous concept with


multiple definitions, and should be replaced with the
concept of “detection limit”
Forensic drug testing laboratories observe strict legal
definitions of “limit of detection” and “limit of quantitation”
The CLSI has recommended protocols for assessing the
precision
i i off clinical
li i l llaboratory
b t methods
th d bboth
th ffor vendors
d
and for end users
There are various methods for validating reference
ranges, from simple comparison to non-parametric
statistical methods

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy